Literature DB >> 30014529

Molecular Probes for Imaging Fibrosis and Fibrogenesis.

Pauline Désogère1,2, Sydney B Montesi3, Peter Caravan1,2.   

Abstract

Fibrosis, or the accumulation of extracellular matrix molecules that make up scar tissue, is a common result of chronic tissue injury. Advances in the clinical management of fibrotic diseases have been hampered by the low sensitivity and specificity of noninvasive early diagnostic options, lack of surrogate end points for use in clinical trials, and a paucity of noninvasive tools to assess fibrotic disease activity longitudinally. Hence, the development of new methods to image fibrosis and fibrogenesis is a large unmet clinical need. Herein, an overview of recent and selected molecular probes for imaging of fibrosis and fibrogenesis by magnetic resonance imaging, positron emission tomography, and single photon emission computed tomography is provided.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  collagen; fibrogenesis; fibrosis; imaging agents; medicinal chemistry

Mesh:

Substances:

Year:  2018        PMID: 30014529      PMCID: PMC6542638          DOI: 10.1002/chem.201801578

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  17 in total

1.  Type I Collagen-targeted Positron Emission Tomography Imaging in Idiopathic Pulmonary Fibrosis: First-in-Human Studies.

Authors:  Sydney B Montesi; David Izquierdo-Garcia; Pauline Désogère; Eric Abston; Lloyd L Liang; Subba Digumarthy; Ravi Seethamraju; Michael Lanuti; Peter Caravan; Ciprian Catana
Journal:  Am J Respir Crit Care Med       Date:  2019-07-15       Impact factor: 21.405

Review 2.  Novel Imaging Approaches in Systemic Sclerosis-Associated Interstitial Lung Disease.

Authors:  Sydney B Montesi; Peter Caravan
Journal:  Curr Rheumatol Rep       Date:  2019-04-25       Impact factor: 4.592

3.  68Ga-NODAGA-Indole: An Allysine-Reactive Positron Emission Tomography Probe for Molecular Imaging of Pulmonary Fibrogenesis.

Authors:  Jessica Wahsner; Pauline Désogère; Eric Abston; Katherine A Graham-O'Regan; Junfeng Wang; Nicholas J Rotile; Markus D Schirmer; Diêgo Dos Santos Ferreira; Jingyi Sui; Bryan C Fuchs; Michael Lanuti; Peter Caravan
Journal:  J Am Chem Soc       Date:  2019-03-27       Impact factor: 15.419

Review 4.  Molecular imaging of fibrosis: recent advances and future directions.

Authors:  Sydney B Montesi; Pauline Désogère; Bryan C Fuchs; Peter Caravan
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

5.  Toward Molecular Imaging of Intestinal Pathology.

Authors:  Mariane Le Fur; Iris Y Zhou; Onofrio Catalano; Peter Caravan
Journal:  Inflamm Bowel Dis       Date:  2020-09-18       Impact factor: 5.325

6.  The Latest Advances in Imaging Crosstalk Between the Immune System and Fibrosis in Cardiovascular Disease.

Authors:  Gyu Seong Heo; Lanlan Lou; Deborah Sultan; Yongjian Liu
Journal:  J Nucl Med       Date:  2021-04-16       Impact factor: 10.057

Review 7.  Location, location, location: how the tissue microenvironment affects inflammation in RA.

Authors:  Christopher D Buckley; Caroline Ospelt; Steffen Gay; Kim S Midwood
Journal:  Nat Rev Rheumatol       Date:  2021-02-01       Impact factor: 20.543

8.  Improving the reactivity of hydrazine-bearing MRI probes for in vivo imaging of lung fibrogenesis.

Authors:  Eman A Akam; Eric Abston; Nicholas J Rotile; Hannah R Slattery; Iris Y Zhou; Michael Lanuti; Peter Caravan
Journal:  Chem Sci       Date:  2019-11-08       Impact factor: 9.825

Review 9.  Current Applications for Nuclear Medicine Imaging in Pulmonary Disease.

Authors:  Joanna E Kusmirek; Josiah D Magnusson; Scott B Perlman
Journal:  Curr Pulmonol Rep       Date:  2020-07-22

Review 10.  Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders.

Authors:  Alexandros Marios Sofias; Federica De Lorenzi; Quim Peña; Armin Azadkhah Shalmani; Mihael Vucur; Jiong-Wei Wang; Fabian Kiessling; Yang Shi; Lorena Consolino; Gert Storm; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2021-06-15       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.